Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ALX148 × Breast × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Trastuzumab 344 Paclitaxel 308 Cyclophosphamide 285 Docetaxel 266 Carboplatin 215 Capecitabine 214 Letrozole 185 Fulvestrant 176 Doxorubicin 166 Bevacizumab 136 Anastrozole 119 Tamoxifen 115 pembrolizumab 112 Epirubicin 110 pertuzumab 108 exemestane 106 Vinorelbine 106 Gemcitabine 106 Albumin-Bound Paclitaxel 92 Lapatinib 84 130-nm albumin-bound paclitaxel 83 Radiotherapy 79 palbociclib 75 eribulin 73 Cisplatin 69 pyrotinib 65 Taxes 65 Everolimus 55 Drug Therapy 50 Goserelin 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07007559 2026-04-13

ASPEN-09-03

ALX Oncology Inc.

Phase 2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡